- Sep 12, 2017 Fortune Magazine Names Jazz Pharmaceuticals 78th Fastest Growing Company for 2017
- Sep 01, 2017 Jazz Pharmaceuticals Announces Completion of Offering and Exercise in Full of Initial Purchasers' Option to Purchase Additional 1.50% Exchangeable Senior Notes due 2024
- Aug 30, 2017 Jazz Pharmaceuticals to Present at the Wells Fargo Securities Healthcare Conference
- Aug 29, 2017 Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products
Data provided by Nasdaq. Minimum 15 minutes delayed.